2022
DOI: 10.1016/j.cels.2022.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 89 publications
(120 reference statements)
2
21
0
Order By: Relevance
“…20 Independent investigations confirmed similar changes in central carbon metabolism in cohorts of patients and in in vivo/in vitro models of infection. [59][60][61][62][63][64][65][66] Our data indicate that a KD increases hepatic metabolic associations with other tissues, a metabolic adaptation also observed in the infected CD group. This suggests that a KD anticipates the systemic metabolic rewiring induced by the virus.…”
Section: Discussionmentioning
confidence: 62%
“…20 Independent investigations confirmed similar changes in central carbon metabolism in cohorts of patients and in in vivo/in vitro models of infection. [59][60][61][62][63][64][65][66] Our data indicate that a KD increases hepatic metabolic associations with other tissues, a metabolic adaptation also observed in the infected CD group. This suggests that a KD anticipates the systemic metabolic rewiring induced by the virus.…”
Section: Discussionmentioning
confidence: 62%
“…Finally, both microbiome and metabolomics are highly dependent upon the genetics, environment, and diet of an individual. The interaction noted may characterize the epiphenomena of a personalized immune system that can be an avenue for future studies to develop a more personalized model for integrative omics to phenotype the disease states that we recently reported (Ambikan et al, 2022).…”
Section: Discussionmentioning
confidence: 98%
“…The similarity network fusion-based patient stratification has been used primarily in non-communicable diseases like cancer [to identify cancer subtypes (Chierici et al , 2020; Wang et al ., 2014) and prognosis(Wang et al , 2021)], respiratory diseases (Narayana et al , 2021) and to study the influence of diet on human health (Burton-Pimentel et al , 2021). Recently we developed SNF-based patient stratification by integrating transcriptomics and metabolomics to define disease severity in COVID-19 that are predictive of the most robust biological features (Ambikan et al , 2022). We also reported the influence of gut microbiota on the systemic metabolic profile associated with disease severity (Albrich et al , 2022).…”
Section: Discussionmentioning
confidence: 99%
“…Ambikan et al presented multi-omics (blood RNA-seq and plasma metabolomics) analyses of personalised networks in which patients were stratified according to the severity of the disease, and which also included reconstruction and analysis of personalised and group-specific GEMs [ 108 ]. Human-GEM [ 23 ] was used as a reference model in the reconstruction.…”
Section: Covid-19 Applications Of Context-specific Genome-scale Metab...mentioning
confidence: 99%